Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1983-5-5
pubmed:abstractText
The catabolite activator protein (CAP) of Escherichia coli, complexed with cAMP, is required for efficient initiation of transcription from the galactose P1 promoter (start site at +1) but not from the overlapping P2 promoter (start site at -5) [Musso, R. E., DiLauro, R., Adhya, S. & deCrombrugghe, B. (1977) Cell 12, 847-854]. We investigated the interactions between CAP/cAMP and the gal promoter region in the presence of RNA polymerase. DNase I protection experiments of gal promoter restriction fragments revealed that CAP/cAMP protects the DNA from digestion between positions -50 and -25 and that RNA polymerase protects it from -35 to +10; however, gal DNA in the presence of both CAP/cAMP and RNA polymerase is protected from DNase I digestion between positions -68 and +15. Results of exonuclease III protection experiments show that RNA polymerase alone protects the gal DNA from -30 to +15; when both CAP/cAMP and RNA polymerase are present in the reaction, protection is afforded from -65 to +20. We directly quantified the amount of cAMP and CAP bound to gal promoter DNA in the presence of RNA polymerase by selectively pelleting the ternary complexes (CAP/cAMP-RNA polymerase-gal promoter DNA) in a Beckman Airfuge. We found two CAP molecules specifically bound to the gal promoter, although only one cAMP molecule was found in the complex at low cAMP concentrations (but sufficient to support P1 transcription). Thus, both the DNA protection experiments and the centrifugation results indicate that RNA polymerase induces the binding of a second CAP molecule to the gal promoter in forming stable initiation complexes. It appears that the second CAP molecule is needed to stimulate initiation from the P1 promoter; this may be involved in regulating the relative rates at which transcription begins from the two gal start sites.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-1101952, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-114520, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-200371, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-217408, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-221831, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-228278, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-319453, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-352408, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-357433, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-368797, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-370784, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-371677, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-6175245, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-6246368, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-6248238, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-6251457, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-6269071, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-6269743, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-6270652, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-6295452, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-6444544, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-6796116, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-6804633, http://linkedlifedata.com/resource/pubmed/commentcorrection/6300859-6941280
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1594-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1983
pubmed:articleTitle
Two catabolite activator protein molecules bind to the galactose promoter region of Escherichia coli in the presence of RNA polymerase.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't